GURUFOCUS.COM » STOCK LIST » Technology » Software » Hestia Insight Inc (OTCPK:HSTA) » Definitions » Total Current Assets

HSTA (Hestia Insight) Total Current Assets : $1.04 Mil (As of Aug. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Hestia Insight Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Hestia Insight's total current assets for the quarter that ended in Aug. 2024 was $1.04 Mil.


Hestia Insight Total Current Assets Historical Data

The historical data trend for Hestia Insight's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hestia Insight Total Current Assets Chart

Hestia Insight Annual Data
Trend Nov22 Nov23
Total Current Assets
0.56 0.17

Hestia Insight Quarterly Data
Feb22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
Total Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.26 0.17 0.19 1.36 1.04

Hestia Insight Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Hestia Insight's Total Current Assets for the fiscal year that ended in Nov. 2023 is calculated as

Hestia Insight's Total Current Assets for the quarter that ended in Aug. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.


Hestia Insight  (OTCPK:HSTA) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Hestia Insight's Liquidation Value for the quarter that ended in Aug. 2024 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.987-0.109+0.75 * 0.049+0.5 * 0
=0.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hestia Insight Total Current Assets Related Terms

Thank you for viewing the detailed overview of Hestia Insight's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Hestia Insight Business Description

Traded in Other Exchanges
N/A
Address
400 South 4th Street, Suite 500, Las Vegas, NV, USA, 89101
Hestia Insight Inc focuses on healthcare and biotech sectors through its subsidiaries: Hestia Investments and Hestia Vending. Hestia Investments offers consulting, supply sales, marketing, and capital markets advisory services to micro, small, and medium-sized companies. Hestia Vending operates in the healthy food, beverage, wellness, and smart vending industries. The company aims for strategic acquisitions of emerging growth companies with sciences and technologies, particularly in healthcare. Revenue comes from annual consulting fees from related party clients.